Top Markets
Coin of the day
Alliance Pharma plc Alliance Pharma plc

Alliance Pharma plc

APH
Clasificación en acciones #13762
Alliance Pharma plc is a pharmaceutical firm with an expansive global reach,... Alliance Pharma plc is a pharmaceutical firm with an expansive global reach, conducting business across Europe, the Middle East, Africa, the Asia Pacific region, China, and the Americas. The company's core activities involve sourcing, promoting, and distributing a diverse array of consumer healthcare items and prescribed medications. It currently manages the marketing rights for approximately 80 different products within these categories. Additionally, its offerings extend to medical devices, dietary supplements, and cosmetic goods. Notable brands within its portfolio include Aloclair, Anbesol, Asthon and Parsons, Atopiclair, Forceval, Hydromol, Kelo-cote, Macushield, Vamousse, Nizoral, and Amberen. Founded in 1996, Alliance Pharma plc maintains its corporate base in Chippenham, United Kingdom.
Precio por acción
$0.85814713
Última sincronización: 2025-05-14
Capitalización bursátil
$463.40M
Cambio (1 día)
-2.52%
Cambio (1 año)
0.00%
País
GB
Comercio Alliance Pharma plc (APH)

Categoría

Ingresos de Alliance Pharma plc (APH)
Ingresos en Dec 2024 TTM: $224.41M
Según los últimos informes financieros de Alliance Pharma plc, los ingresos actuales de la empresa (TTM) son $224.41M. En 2023, la empresa obtuvo unos ingresos de $230.01M un aumento con respecto a los ingresos del año 2022, que fueron de $202.54M. Los ingresos representan la cantidad total que una empresa genera por la venta de bienes o servicios. A diferencia de las ganancias, no se restan los gastos.
Historial de ingresos de Alliance Pharma plc desde 2001 hasta 2026
Ingresos al final de cada año
Año Ingresos Cambiar
2026 (TTM) $224.41M 0.00%
2024 $224.41M -2.43%
2023 $230.01M 13.56%
2022 $202.54M -8.21%
2021 $220.65M 24.34%
2020 $177.46M -1.34%
2019 $179.87M 19.46%
2018 $150.56M 7.84%
2017 $139.62M 16.04%
2016 $120.32M 68.90%
2015 $71.24M 5.03%
2014 $67.83M -10.01%
2013 $75.38M 3.50%
2012 $72.83M 2.12%
2011 $71.32M -8.14%
2010 $77.64M 53.57%
2009 $50.56M 59.16%
2008 $31.76M -12.52%
2007 $36.31M 7.34%
2006 $33.83M 60.14%
2005 $21.13M 9.03%
2004 $19.38M 44.44%
2002 $13.42M 51.66%
2001 $8.85M 0.00%
Ingresos de empresas similares o competidoras